{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T13:40:08Z","timestamp":1746884408040,"version":"3.40.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017160","name":"Beni-Suef University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jchromb.2025.124612","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T15:57:53Z","timestamp":1745596673000},"page":"124612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A superior method for the estimation of Molnupiravir and its metabolite and degradation product, Beta-D-N4-Hydroxycytidine, in human plasma with dexamethasone"],"prefix":"10.1016","volume":"1259","author":[{"given":"Aml A.","family":"Emam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eglal A.","family":"Abdelaleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esraa H.","family":"Abdelmomen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Refaat H.","family":"Abdelmoety","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.M.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehab M.","family":"Abdelfatah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2025.124612_bb0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/metabo13020309","article-title":"Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants","volume":"13","author":"Teli","year":"2023","journal-title":"Metabolites"},{"author":"WHO","key":"10.1016\/j.jchromb.2025.124612_bb0010"},{"key":"10.1016\/j.jchromb.2025.124612_bb0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","article-title":"World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)","volume":"76","author":"Sohrabi","year":"2020","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.jchromb.2025.124612_bb0020","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(21)00306-8","article-title":"Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment","volume":"397","author":"Wouters","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jchromb.2025.124612_bb0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00705-023-05881-9","article-title":"Molnupiravir: an antiviral drug against COVID-19","volume":"168","author":"Dave","year":"2023","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jchromb.2025.124612_bb0030","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41594-021-00657-8","article-title":"Molnupiravir: coding for catastrophe","volume":"28","author":"Malone","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jchromb.2025.124612_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/infdis\/jiab247","article-title":"\u0392-D-N4-hydroxycytidine inhibits SARS-CoV-2 through lethal mutagenesis but is also mutagenic to mammalian cells","volume":"224","author":"Zhou","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jchromb.2025.124612_bb0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/microorganisms13030669","article-title":"Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case\u2013Control Study (SAVALO Study)","volume":"13","author":"Gentile","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.jchromb.2025.124612_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2024.12.016","article-title":"Molnupiravir for high-risk adults with COVID-19: target trial emulation in a Japanese cohort","volume":"31","author":"Kimura","year":"2025","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.jchromb.2025.124612_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2024.10.026","article-title":"Real-world effectiveness of nirmatrelvir-ritonavir and molnupiravir in non-hospitalized adults with COVID-19: a population-based, retrospective cohort study","volume":"31","author":"Jorda","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jchromb.2025.124612_bb0055","series-title":"Analytical Profiles of Drug Substances and Excipients","first-page":"9","volume":"2","author":"Florey","year":"1973"},{"key":"10.1016\/j.jchromb.2025.124612_bb0060","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s42399-020-00610-8","article-title":"Dexamethasone for the treatment of coronavirus disease (COVID-19): a review","volume":"2","author":"Ahmed","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"10.1016\/j.jchromb.2025.124612_bb0065","first-page":"1","article-title":"White targeted chromatographic screening method of Molnupiravir and its metabolite with degradation kinetics characterization and in-silico toxicity","volume":"13","author":"Aboras","year":"2023","journal-title":"Scientific Reports 2023"},{"key":"10.1016\/j.jchromb.2025.124612_bb0070","first-page":"1","article-title":"A sustainable approach for the degradation kinetics study and stability assay of the SARS-CoV-2 oral antiviral drug Molnupiravir","volume":"13","author":"Edrees","year":"2023","journal-title":"Scientific Reports 2023"},{"key":"10.1016\/j.jchromb.2025.124612_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.18231\/j.ijpca.2022.006","article-title":"Quantitative estimation of molnupiravir by UV- spectrophotometric method","volume":"9","author":"Jain","year":"2022","journal-title":"Int. J. Pharm. Chem. Analysis"},{"key":"10.1016\/j.jchromb.2025.124612_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-023-00933-2","article-title":"Earth-friendly-assessed silver-nanoparticles spectrophotometric method for rapid and sensitive analysis of Molnupiravir, an FDA-approved candidate for COVID-19: application on pharmaceutical formulation and dissolution test","volume":"17","author":"Mohamed","year":"2023","journal-title":"BMC Chem"},{"key":"10.1016\/j.jchromb.2025.124612_bb0085","first-page":"256","article-title":"Determination of Molnupiravir by extractive colorimetric method from pharmaceutical dosage form","volume":"15","author":"Rajan","year":"2022","journal-title":"Asian J. Research Chem"},{"key":"10.1016\/j.jchromb.2025.124612_bb0090","first-page":"439","article-title":"A validated potentiometric titration method for quantitative determination of Molnupiravir from pharmaceutical preparation","volume":"15","author":"RRV","year":"2022","journal-title":"Asian J. Res. Chem."},{"key":"10.1016\/j.jchromb.2025.124612_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2022.108195","article-title":"Voltammetric determination of Molnupiravir used in treatment of the COVID-19 at magnetite nanoparticle modified carbon paste electrode","volume":"184","author":"Vural","year":"2023","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2025.124612_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114693","article-title":"A stability indicating RP-HPLC method for determination of the COVID-19 drug molnupiravir applied using nanoformulations in permeability studies","volume":"214","author":"Re\u00e7ber","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124612_bb0105","first-page":"1","article-title":"White targeted chromatographic screening method of Molnupiravir and its metabolite with degradation kinetics characterization and in-silico toxicity","volume":"13","author":"Aboras","year":"2023","journal-title":"Scientific Reports 2023"},{"key":"10.1016\/j.jchromb.2025.124612_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114356","article-title":"The development and validation of a novel LC-MS\/MS method for the simultaneous quantification of Molnupiravir and its metabolite \u00df-d-N4-hydroxycytidine in human plasma and saliva","volume":"206","author":"Amara","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124612_bb0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.25004\/IJPSDR.2023.150301","article-title":"Stability indicating RP-HPLC method development for the estimation of Molnupiravir in capsule dosage form","volume":"15","author":"Tarole","year":"2023","journal-title":"International J. Pharma. Sci. Drug Res."},{"key":"10.1016\/j.jchromb.2025.124612_bb0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.47583\/ijpsrr.2024.v84i03.028","article-title":"Reverse phase-liquid chromatography assisted protocol for determination of Molnupiravir medication used to SARS-CoV-2 infection: an investigative approach","volume":"84","author":"Ambhore","year":"2024","journal-title":"Int. J Pharm Sci Rev Res"},{"key":"10.1016\/j.jchromb.2025.124612_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123363","article-title":"A validated LC-MS\/MS method for determination of antiviral prodrug molnupiravir in human plasma and its application for a pharmacokinetic modeling study in healthy Egyptian volunteers","volume":"1206","author":"Gouda","year":"2022","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2025.124612_bb0130","doi-asserted-by":"crossref","first-page":"34512","DOI":"10.1039\/D2RA05066H","article-title":"Development and validation of molnupiravir assessment in bulk powder and pharmaceutical formulation by the RP-HPLC-UV method","volume":"12","author":"Annadi","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.jchromb.2025.124612_bb0135","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1007\/s00216-023-04811-7","article-title":"Determination of anti-SARS-CoV-2 virustatic pharmaceuticals in the aquatic environment using high-performance liquid chromatography high-resolution mass spectrometry","volume":"415","author":"Bartels","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2025.124612_bb0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.33380\/2305-2066-2023-12-1-215-226","article-title":"Simultaneous determination of major Molnupiravir metabolite (\u03b2-D-N4-hydroxycytidine) and Favipiravir in human plasma by HPLC-MS\/MS","volume":"12","author":"Komarov","year":"2023","journal-title":"Drug Develop.Registration"},{"key":"10.1016\/j.jchromb.2025.124612_bb0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4236\/ijoc.2014.41004","article-title":"Influence of microwave irradiation on hydrolysis reaction of sunflower oil in aqueous emulsion","volume":"4","author":"Mazouzi-Sennour","year":"2014","journal-title":"Int J Org Chem (Irvine)"},{"key":"10.1016\/j.jchromb.2025.124612_bb0155","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1080\/00397910008087033","article-title":"An efficient and general method for Ester hydrolysis on the surface of silica gel catalyzed by indium triiodide under microwave irradiation","volume":"30","author":"Ranu","year":"2000","journal-title":"Synth. Commun."},{"key":"10.1016\/j.jchromb.2025.124612_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arabjc.2010.06.009","article-title":"Microwave-assisted expeditious hydrolysis of isobenzofuranone derivatives using silica supported acid under organic solvent-free conditions","volume":"4","author":"Safari","year":"2011","journal-title":"Arab. J. Chem."},{"author":"The United States Food and Drug Administration","key":"10.1016\/j.jchromb.2025.124612_bb0165"},{"key":"10.1016\/j.jchromb.2025.124612_bb0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/AAC.02428-20","article-title":"Human safety, tolerability, and pharmacokinetics of Molnupiravir, a novel broad-Spectrum Oral antiviral agent with activity against SARS-CoV-2","volume":"65","author":"Painter","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2025.124612_bb0175","first-page":"1","article-title":"Introduction to green sample preparation","author":"Canpolat","year":"2023","journal-title":"Green Sample Preparation Techniques"},{"key":"10.1016\/j.jchromb.2025.124612_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.greeac.2022.100007","article-title":"Alternative green solvents in sample preparation","volume":"1","author":"Armenta","year":"2022","journal-title":"Green Analytical Chem."},{"key":"10.1016\/j.jchromb.2025.124612_bb0185","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2174\/0113816128266396231017072043","article-title":"Tools to evaluate the eco-efficiency of analytical methods in the context of green and white analytical chemistry: a review","volume":"29","author":"Sinzervinch","year":"2023","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jchromb.2025.124612_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2023.117196","article-title":"Green metric tools for analytical methods assessment critical review, case studies and crucify","volume":"166","author":"Kowtharapu","year":"2023","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2025.124612_bb0195","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.3390\/molecules29133205","article-title":"Enhancing Sustainable Analytical Chemistry in Liquid Chromatography: Guideline for Transferring Classical High-Performance Liquid Chromatography and Ultra-High-Pressure Liquid Chromatography Methods into Greener, Bluer, and Whiter Methods","volume":"29","author":"El Deeb","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2025.124612_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2024.126324","article-title":"A stability-indicating HPLC assay of ten different vitamins in a food supplement: appraisal of the method\u2019s greenness, whiteness, and blueness","volume":"277","author":"Abdelfatah","year":"2024","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2025.124612_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2024.111255","article-title":"Greenness and practicability assessment of a new HPLC-DAD method for simultaneous determination of three drugs used for a triple-therapy regimen for helicobacter pylori and application to a pharmacokinetic study","volume":"205","author":"Abdelfatah","year":"2024","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2025.124612_bb0210","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE - analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2025.124612_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.sampre.2022.100025","article-title":"A tutorial on AGREEprep an analytical greenness metric for sample preparation","volume":"3","author":"Pena-Pereira","year":"2022","journal-title":"Adv. Sample Preparation"},{"key":"10.1016\/j.jchromb.2025.124612_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2021.116223","article-title":"White analytical chemistry: an approach to reconcile the principles of green analytical chemistry and functionality","volume":"138","author":"Nowak","year":"2021","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2025.124612_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2024.117524","article-title":"Comparison of various sample preparation methods for benzodiazepines in terms of the principles of white analytical chemistry","volume":"171","author":"Jain","year":"2024","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2025.124612_bb0230","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1039\/D3GC02347H","article-title":"Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality","volume":"25","author":"Manousi","year":"2023","journal-title":"Green Chem."},{"key":"10.1016\/j.jchromb.2025.124612_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2024.117586","article-title":"Novel sorptive extraction techniques in bioanalysis evaluated by blue applicability grade index: the paradigm of fabric phase sorptive extraction and capsule phase microextraction","volume":"172","author":"Manousi","year":"2024","journal-title":"TrAC Trends Anal. Chem."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225001667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225001667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T13:12:31Z","timestamp":1746882751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023225001667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"alternative-id":["S1570023225001667"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124612","relation":{},"ISSN":["1570-0232"],"issn-type":[{"type":"print","value":"1570-0232"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A superior method for the estimation of Molnupiravir and its metabolite and degradation product, Beta-D-N4-Hydroxycytidine, in human plasma with dexamethasone","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124612"}}